A newly discovered genetic variant in 30% of patients with pulmonary arterial hypertension predicts early heart failure, providing a vital tool for life-saving early intervention and transplant prioritization.
Most Recent Articles
Impact of Respiratory Stability on the Prevalence of Non-Fatal MACCEs
New research reveals that people with fluctuating sleep apnea are 30% more likely to suffer heart attacks, proving that nightly consistency matters as much as overall severity.
Cryo-EM Visualization of the Active Thromboxane Receptor Complex
Scientists have uncovered a high-resolution molecular map of a critical blood-clotting receptor, opening the door for new treatments for cardiovascular disease, pulmonary hypertension, and inflammatory disorders.
Genetic Risk Scores for Diabetes Subgroups as Predictors of Coronary Artery Disease
A breakthrough study shows that a person’s genetic risk for a specific diabetes subgroup can predict heart disease years before any diabetic symptoms actually appear
Impact of Fluvoxamine on Quality of Life and Fatigue Severity in Long COVID
Fluvoxamine, a common antidepressant, significantly reduces the persistent fatigue associated with long COVID, whereas the diabetes drug metformin proved ineffective.
